HR 2851 115th Congress House Crime and Law Enforcement Administrative law and regulatory procedures Criminal procedure and sentencing Drug trafficking and controlled substances Fraud offenses and financial crimes Licensing and registrations Medical research U.S. Sentencing Commission

SITSA Act

Introduced: November 1, 2017 See on congress.gov

Everywhere this bill has been 23 steps

Introduced

In committee

Reported out

Passed House

Passed Senate

To President

Became law

Jun 18, 2018

Received in the Senate and Read twice and referred to the Committee on the Judiciary.

Jun 15, 2018

The House rose from the Committee of the Whole House on the state of the Union to report H.R. 2851.

Jun 15, 2018

Motion to reconsider laid on the table Agreed to without objection.

Jun 15, 2018

On passage Passed by recorded vote: 239 - 142 (Roll no. 268).

Jun 15, 2018

The House adopted the amendment in the nature of a substitute as agreed to by the Committee of the Whole House on the state of the Union.

Jun 15, 2018

The previous question was ordered pursuant to the rule.

Jun 15, 2018

DEBATE - Pursuant to the provisions of H. Res. 934, the Committee of the Whole proceeded with 10 minutes of debate on the Thornberry amendment No. 4.

Jun 15, 2018

DEBATE - Pursuant to the provisions of H. Res. 934, the Committee of the Whole proceeded with 10 minutes of debate on the Sean Maloney amendment No. 3.

Jun 15, 2018

DEBATE - Pursuant to the provisions of H. Res. 934, the Committee of the Whole proceeded with 10 minutes of debate on the Jackson Lee amendment No. 2.

Jun 15, 2018

DEBATE - Pursuant to the provisions of H. Res. 934, the Committee of the Whole proceeded with 10 minutes of debate on the Griffith amendment No. 1.

Jun 15, 2018

GENERAL DEBATE - The Committee of the Whole proceeded with one hour of general debate on H.R. 2851.

Jun 15, 2018

The Speaker designated the Honorable Mike Bost to act as Chairman of the Committee.

Jun 15, 2018

House resolved itself into the Committee of the Whole House on the state of the Union pursuant to H. Res. 934 and Rule XVIII.

Jun 15, 2018

Rule provides for consideration of H.R. 2851, H.R. 5735 and H.R. 5788 with 1 hour of general debate. Previous question shall be considered as ordered without intervening motions except motion to recommit with or without instructions. Measure will be considered read. Specified amendments are in order.

Jun 15, 2018

Considered under the provisions of rule H. Res. 934. (consideration: CR H5204-5221; text of amendment in the nature of a substitute: CR H5212-5215)

Jun 12, 2018

Rules Committee Resolution H. Res. 934 Reported to House. Rule provides for consideration of H.R. 2851, H.R. 5735 and H.R. 5788 with 1 hour of general debate. Previous question shall be considered as ordered without intervening motions except motion to recommit with or without instructions. Measure will be considered read. Specified amendments are in order.

Jun 8, 2018

Reported (Amended) by the Committee on Judiciary. H. Rept. 115-713, Part I.

Jul 12, 2017

Ordered to be Reported (Amended) by Voice Vote.

Jul 12, 2017

Committee Consideration and Mark-up Session Held.

Jun 9, 2017

Referred to the Subcommittee on Health.

Jun 8, 2017

Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.

Jun 8, 2017

Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Jun 8, 2017

Introduced in House

Votes taken on this bill 1

Date	Chamber	What was voted on	Result	Yes–No
Jun 15, 2018	House · vote #268	On Passage	Passed	239–142	See who voted →

Amendments to this bill 4

Amendments propose changes to this bill. Members vote on amendments separately before the final bill vote. An agreed amendment becomes part of the bill; a failed amendment does not.

4 agreed to

Amendment	Sponsor	Purpose	Status	Latest action
HAMDT 791	—	Amendment specifies the factors to determine whether a controlled substance analogue is intended for human co…	Agreed to	Jun 15, 2018
HAMDT 790	—	An amendment numbered 3 printed in Part A of House Report 115-751 to require the Drug Enforcement Administrat…	Agreed to	Jun 15, 2018
HAMDT 789	—	An amendment numbered 2 printed in Part A of House Report 115-751 to strike the sentencing commission provisi…	Agreed to	Jun 15, 2018
HAMDT 788	Griffith, H. Morgan	An amendment numbered 1 printed in Part A of House Report 115-751 to incorporate an inter-agency agreement tr…	Agreed to	Jun 15, 2018

Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

Plain-English summary Congressional Research Service

Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 or the SITSA Act

This bill amends the Controlled Substances Act to establish a new, sixth schedule of controlled substances—schedule A. A drug or substance in schedule A has a chemical structure that is similar to, and an effect on the body that is similar to or greater than, a controlled substance in schedule I, II, III, IV, or V.

The bill adds 13 synthetic fentanyl-related substances to schedule A. It also authorizes, and establishes procedures for, the Drug Enforcement Administration (DEA) to temporarily and permanently place a drug or substance in schedule A.

The bill establishes criminal penalties for an individual who imports, exports, manufactures, distributes, or possesses with intent to distribute a schedule A substance. However, it explicitly prohibits criminal and civil penalties solely for possession of a schedule A controlled substance.

The bill makes it unlawful to import, export, manufacture, distribute, dispense, or possess with intent to manufacture, distribute, or dispense, a schedule A substance that is not clearly labeled.

Finally, it establishes new, separate DEA registration requirements for manufacturers, distributors, and importers and exporters of schedule A substances.

What's happening now June 18, 2018

Received in the Senate and Read twice and referred to the Committee on the Judiciary.

Related & companion bills 7